Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,836
Closed -$1.49M 870
2025
Q2
$1.64M Buy
18,836
+6,140
+48% +$481K 0.16% 85
2025
Q1
$867K Sell
12,696
-6,008
-32% -$490K 0.09% 135
2024
Q4
$1.45M Buy
18,704
+5,654
+43% +$419K 0.13% 104
2024
Q3
$875K Sell
13,050
-6,621
-34% -$544K 0.1% 132
2024
Q2
$2.23M Buy
+19,671
New +$2.49M 0.27% 73
2020
Q1
Sell
-131,636
Closed -$8.19M 1277
2019
Q4
$7.2M Buy
+131,636
New +$6.24M 0.39% 47

Other funds holding DXCM

HAP Trading's DXCM Position: Q3 2025 in Review

HAP Trading sold out of DexCom (DXCM) in Q3 2025, closing a stake of 18,836 shares — an estimated $1.49M sold.

HAP Trading first reported a position in DXCM in Q4 2019 and held it in 6 quarters. The position peaked at $7.2M in Q4 2019. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • HAP Trading reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • HAP Trading sold 18,836 DexCom shares in Q3 2025, an estimated $1.49M.
  • HAP Trading first reported a position in DexCom in Q4 2019 and held it in 6 quarters.
  • HAP Trading's DexCom position peaked at $7.2M in Q4 2019.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.